UNSPSC 51283407: Pheneticillin or phenethicillin

This classification denotes a penicillin v analog and anti-bacterial agent with the molecular formula C17H20N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EFA30X554H, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenoxypropionamido)- but generally known as pheneticillin, which bears US NIH Compound Identifier 4759. European Medicines Agency schedules Pheneticillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09759MIG.

World Health Organization schedules pheneticillin in its Anatomical Therapeutic Chemical (ATC) Classification. PHENETICILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S1C2N(C(C1(C)C)C(=O)O)C(=O)C2NC(=O)C(OC1CCCCC1)C.

UNSPSC 51283407 Pheneticillin or phenethicillin is a Commodity code, but state and local procurement activity under this code shows a fundamental mismatch between its nominal scope and what is actually being solicited. Recent opportunities tagged to this code involve naloxone, medical and first aid supplies for fire-rescue operations, generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing, and direct-to-manufacturer prescription programs — none of which align with pheneticillin or phenethicillin, a specific penicillin-class antibiotic with limited modern clinical use. The code does not reflect the work state and local governments are actually buying under this classification.

The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), municipal fire departments (City of Tampa), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). Recent opportunities span Florida, Texas, and Minnesota, with the largest recent procurement being the Minnesota MMCAP RFP for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, and the City of Tampa IFB for medical and first aid supplies (26P00145), an estimated $700,000 contract designated for certified Small Local Business Enterprises with a 5 percent bid discount, due March 13, 2026. Seminole County posted an IFB (IFB60459723LAS) for naloxone and drug deactivation systems, due July 26, 2023 (with an administrative date discrepancy in the source). The Texas HHS Commission issued an RFI on March 27, 2026 (response due April 3, 2026) to solicit vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program. The code's recent activity reflects procurement of emergency medical supplies, public-health pharmaceuticals, and pharmacy benefit management infrastructure rather than the specific antibiotic its nominal name describes.